end stage renal disease (ESRD) , patency of internal jugular permcath , aspirin consumption. Encounter for adjustment and management of vascular access device
Conditions
Interventions
Intervention 1: Intervention group: Receive 80 mg aspirin orally, once a day , for 6 months, made by Parsdarou Company The survi
Sponsors
Zanjan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The patient has ESRD and Glomerular Filtration Rate (GFR) <15ml / min / 1.73 m^2. At least one month should be passed since the start of hemodialysis maintenance. At least one month and at most one year should be passed since the installation of the internal jugular permcath . There shouldn't have any definitive contraindication for normal use of aspirin
Exclusion criteria
Exclusion criteria: Current aspirin use at the time of entrance in the study Presence of a known underlying disease that increases the risk of thrombosis (lupus, antiphospholipid syndrome, presence of nephrotic syndromes) use of anticoagulants (warfarin, heparin, apixaban, rivaroxaban, plavix) use of Tarulac Catheter infection before beginning the study Incomplete patient document regarding the items required in the study Patient disfavor with inclusion in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration of internal jugular permcath patency. Timepoint: Weekly. Method of measurement: Number of days that permcath has function during the 6 month of the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of time that patient has suffered from End Stage Renal Disease (ESRD). Timepoint: At onset of study. Method of measurement: Number of months passed since the diagnosis of ESRD and onset of hemodialysis.;History of heart failure. Timepoint: At onset of the study. Method of measurement: Ejection Fraction (EF) less than 50% according to echocardiography record in patient's file.;Hypertension. Timepoint: At onset of the study and in patients with hypertension, weekly until the end of the study. Method of measurement: Systolic blood pressure (SBP) = 140 mmHg or Diastolic blood pressure (DBP) = 90 mmHg according to patient's file.;Diabetes mellitus. Timepoint: At onset of the study. Method of measurement: Fast Blood Sugar (FBS) = 126 mg/dl according to patient's file.;Age. Timepoint: At onset of the study. Method of measurement: Asking from patient.;Sex. Timepoint: At onset of the study. Method of measurement: Observation. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHanieh Davoodi
Zanjan University of Medical Sciences
Outcome results
None listed